These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5020603)

  • 1. Drug efficacy and a journal's responsibility.
    Kimmey JR
    Am J Public Health; 1972 Apr; 62(4):461-2. PubMed ID: 5020603
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 3. Who reviews the ads?
    Relman AS
    N Engl J Med; 1979 Nov; 301(18):999. PubMed ID: 492232
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct-to-consumer advertising--education or emotion promotion?
    Wolfe SM
    N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857
    [No Abstract]   [Full Text] [Related]  

  • 5. Information contained in drug advertisements.
    Stimson GV
    Br Med J; 1975 Nov; 4(5995):508-9. PubMed ID: 1192148
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward more effective drug regulation.
    Schmidt AM
    FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532
    [No Abstract]   [Full Text] [Related]  

  • 7. Report suggests steps to improve safety of drug supply.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract]   [Full Text] [Related]  

  • 9. U.S. v. Barr Laboratories: a technical perspective.
    Madsen RE
    PDA J Pharm Sci Technol; 1994; 48(4):176-9. PubMed ID: 7804814
    [No Abstract]   [Full Text] [Related]  

  • 10. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimum acceptable requirements for introduction and marketing of drugs.
    Lasagna L
    Drugs; 1974; 7(6):409-13. PubMed ID: 4422210
    [No Abstract]   [Full Text] [Related]  

  • 12. OTC's: end the dual standard.
    Feldmann EG
    J Pharm Sci; 1973 Apr; 62(4):I. PubMed ID: 4699002
    [No Abstract]   [Full Text] [Related]  

  • 13. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER
    N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
    [No Abstract]   [Full Text] [Related]  

  • 14. Truth in advertising: the journal's responsibility.
    Atkins RF
    Anesthesiology; 1991 Sep; 75(3):547-8. PubMed ID: 1888068
    [No Abstract]   [Full Text] [Related]  

  • 15. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 16. Today's dilemma--will drugs work?
    Dowling HF
    J Am Pharm Assoc; 1971 Jun; 11(6):331-3. PubMed ID: 5118797
    [No Abstract]   [Full Text] [Related]  

  • 17. The responsibility of FDA to the livestock industry and the consumer. II. Considerations for conducting investigational studies with food-producing animals.
    Graber G; Thomas MC
    J Anim Sci; 1973 Jul; 37(1):215-6. PubMed ID: 4720860
    [No Abstract]   [Full Text] [Related]  

  • 18. The economic wisdom of regulating pharmaceutical "freebies".
    Fisher SH
    Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416
    [No Abstract]   [Full Text] [Related]  

  • 19. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary wholesalers oppose FDA pedigree regulation.
    Young D
    Am J Health Syst Pharm; 2001 Sep; 58(18):1698, 1700. PubMed ID: 11571811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.